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Abstract   
Descending controls of spinal nociceptive processing play a critical role in the 
development of inflammatory hyperalgesia. Acute peripheral nociceptor 
sensitisation drives spinal sensitisation, and activates spino-supraspinal-
spinal loops leading to descending inhibitory and facilitatory controls of spinal 
neuronal activity, that further modify the extent and degree of the pain state. 
The afferent inputs from hairy and glabrous skin are distinct with respect to 
both the profile of primary afferents classes and the degree of their peripheral 
sensitisation. It is not known whether these differences in afferent input 
differentially engage descending control systems to different extents or in 
different ways.  
Injection of Complete Freund’s adjuvant resulted in inflammation and swelling 
of hairy hindpaw skin in rats, a transient thermal hyperalgesia lasting <2 
hours, and long-lasting primary mechanical hyperalgesia (at least 7d). Much 
longer lasting thermal hyperalgesia was apparent in glabrous skin (1h up to 
>72h). In hairy skin, transient hyperalgesia was associated with sensitisation 
of withdrawal reflexes to thermal activation of either A- and C-nociceptors. 
The transience of the hyperalgesia was attributable to a rapidly engaged 
descending inhibitory noradrenergic mechanism, which affected withdrawal 
responses to both A- and C-nociceptor activation and this could be reversed 
by intrathecal administration of yohimbine (alpha-2-adrenoceptor antagonist). 
In glabrous skin, yohimbine had no effect on an equivalent thermal 
inflammatory hyperalgesia.   
We conclude that acute inflammation and peripheral nociceptor sensitisation 
in hind paw hairy skin, but not glabrous skin, rapidly activates a descending 
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inhibitory noradrenergic system. This may result from differences in the 
engagement of descending controls systems following sensitisation of 
different primary afferent classes that innervate glabrous and hairy skin.  
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Key Points 
• Acute inflammation engages various descending control systems in the 
brain that alter the resulting inflammatory pain, usually by inhibiting it.  
• In this study we looked at the differences in inhibition of acute (up to 
3h) inflammatory pain from the smooth (glabrous) and the hairy skin in 
the rat hind-paw. 
• In hairy skin, inflammatory pain is rapidly inhibited by descending 
systems that release noradrenaline, but not opiates, into the spinal 
cord.  
• In glabrous skin, neither descending noradrenergic nor opioidergic 
controls affect inflammatory pain.  
• These results tell us that the controls on the spinal processing of 
cutaneous inflammatory pain are different depending on the skin type 
affected.  
 
 
 
Abbreviations  
Periaqueductal grey (PAG), locus coeruleus (LC), rostroventral medulla 
(RVM), Complete Freund’s adjuvant (CFA) 
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Introduction  
Tissue damage and subsequent inflammation activates and sensitises 
peripheral nociceptors. This increases afferent input to central nociceptive 
circuits and leads to enhanced sensitivity to nociceptive stimuli (hyperalgesia), 
and sensations of pain to innocuous stimulation (allodynia) (Meyer et al., 
2005; Latremoliere & Woolf, 2009). Peripheral nociceptive inputs drive both 
the sensitisation of spinal nociceptive circuits and the activation of ascending 
and descending pathways that together modulate transmission, and ultimately 
perception, of nociceptive information (Mantyh & Hunt, 2004). The final 
perception of the intensity and quality of pain is determined by the degree of 
such modulation of information throughout the nociceptive neuraxis (Ossipov 
et al., 2010). 
It is well established that spinal nociceptive processing is modulated by both 
inhibitory and facilitatory descending pathways that originate supraspinally 
(Millan, 2002). The midbrain periaqueductal grey (PAG) forms a major 
component of the descending nociceptive system and relays via brain stem 
nuclei such as locus coeruleus (LC) and the rostroventral medulla (RVM) 
(Mantyh, 1983; Bajic & Proudfit, 1999) to exert controls on spinal nociceptive 
neurons. Descending controls from the PAG include opioidergic (Przewłocki & 
Przewłocka, 2001;Vasquez & Vanegas, 2000; Kwok et al., 2013) and 
monoaminergic inhibition (Pertovaara, 2006) as well as prostanergic 
facilitation (Oliva et al., 2006; Leith et al., 2007; Palazzo et al., 2011). 
Medullary and brain stem nuclei are major sources of spinally projecting 
monoaminergic fibres (Westlund et al 1983; Yoshimura & Furue, 2006) that 
are known to exert inhibitory influences, which modulate the development of 
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acute and persistent pain states (Vanegas & Schaible, 2004; Pertovaara, 
2006, 2013; Yoshimura & Furue, 2006). Descending noradrenergic systems 
exert these inhibitory influences largely through presynaptic inhibition, 
primarily through alpha-2-adrenoceptor activation (Pertovaara, 2006; 
Yoshimura & Furue, 2006). Alpha-2-agonists, in particular those with affinity 
for alpha 2A receptors, are antinociceptive in both animals and humans 
(Pertovaara, 2006). Descending serotonergic systems exert complex pro- and 
anti-nociceptive effects at the spinal level, primarily through 5-HT1 and 5-HT3 
autoreceptors (Yoshimura & Furue, 2006; Dogrul et al., 2009; Jeong et al., 
2012). Additionally there are peripheral sources of monoamines, such as 
sympathetic fibres within the dorsal root ganglia, that are able to impact upon 
nociception during periods of prolonged inflammation or tissue damage 
(Pertovaara, 2006). Peripheral nerve stimulation evokes spinal release of 
monoamines in the presence of ganglionic blocking agents (Tyce & Yaksht, 
1981), however, so it is widely accepted that the major sources of spinal 
noradrenaline and serotonin are projections from medullary and brain stem 
nuclei (Pertovaara, 2006; Yoshimura & Furue, 2006).  
Acute cutaneous inflammation leads to sensitisation of peripheral and central 
nociceptive neurons resulting in primary and secondary hyperalgesia. 
Descending controls of the spinal processing of input from the area of primary 
hyperalgesia is initially facilitatory from, for example PAG/RVM, but are short-
lived (up to 3h), and are then overwhelmed by local spinal and supraspinal 
inhibitory influences (Ren & Dubner, 1996; Guan et al., 2002; Miki et al., 2002; 
Vanegas & Schaible, 2004).The dampening effect of the inhibitory systems on 
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spinal dorsal horn activity effectively reduces the extent of inflammatory pain 
by limiting central sensitisation (Vanegas & Schaible, 2004). 
Current understanding of the development of inflammatory hyperalgesia and 
the influence of descending controls over spinal nociceptive processing is 
largely derived from animal models using inflammatory insults to the glabrous 
skin of the hindpaw. There is little information on the contribution of 
descending controls to the development or maintenance of primary 
hyperalgesia in hairy skin, which is a potential shortcoming given this is the 
more prevalent skin type in mammals. Glabrous cutaneous tissue found on 
the plantar surface of the paw forms a major informative surface of the body 
providing critical sensory/discriminative information about the environment. 
This is reflected by a greater density of primary afferents innervating glabrous 
tissue and its over representation in cortical somatotopic maps (Blake et al., 
2002; Provitera et al., 2007; Boada et al., 2013). There are notable 
differences in the profile of nociceptive afferent fibres that innervate glabrous 
and hairy cutaneous tissue, for instance, a threefold higher proportion of fast 
conducting to slowly conducting fibres innervating glabrous cutaneous tissue 
(Boada et al., 2013) and a large proportion of C-polymodal nociceptors 
innervating the hairy skin of the rat hind-paw (Lynn & Carpenter, 1982; Leem 
et al., 1993).  Critically, there are differences in the sensitisation of 
unmyelinated nociceptive afferents innervating the two skin types. Following 
application of conditioning stimuli or sensitising agents, a population of 
polymodal C-nociceptors found in glabrous skin fail to sensitise to thermal 
stimuli but a similar population of polymodal C-nociceptors found in hairy 
cutaneous tissue do sensitise, with a lowering of activation threshold and/or 
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increased suprathreshold response (Campbell & Meyer, 1983; Andrew & 
Greenspan, 1999; Koerber et al., 2010). We hypothesised that during 
inflammation, the differences in primary afferent input from different skin types 
might differentially drive descending control systems and hence differentially 
affect the development of inflammatory hyperalgesia in the two skin types. 
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Materials and Methods 
All experiments were performed in accordance with United Kingdom Animals 
(Scientific Procedures) Act (1986) and associated guidelines. Animals were 
housed in standard conditions with food and water provided ad libitum. 
Experiments were performed on a total of 58 male Wistar rats weighing 250-
350g. The majority of animals (n=55) received a subcutaneous (s.c.) injection 
of 50 or 100µg Complete Freund’s Adjuvant (CFA) (1mg/ml; Cat No: F5881, 
Sigma-Aldrich, UK) into either dorsal or ventral surface of the left hind-paw 
under brief halothane (3% in O2) anaesthesia. Control animals (n=3) received 
a s.c. injection of an equivalent volume of vehicle (mineral oil). CFA induces a 
dose dependent increase in swelling, in both rat and mouse, up to doses of 
250µg and 500µg respectively. This CFA dose/volume (50µg/50µl) gives a 
mild, limited inflammation that is less than the maximal achievable with CFA, 
and that does not spread to involve the sides or other surface of the hindpaw. 
Greater swelling and spread of inflammation can be seen with higher doses of 
CFA (Donaldson et al., 1993; Chillingworth et al., 2006). Although differences 
in oedema have been previously reported with higher CFA doses (Cook & 
Moore, 2006), we chose to investigate the effects of equivalent inflammatory 
stimuli in this study, rather than equivalent oedematous responses.  
Nociceptive behavioural testing. 
To assess the effect of s.c. CFA injections at different sites on nociceptive 
behaviour, some animals (n=7) underwent nociceptive testing before, three 
hours, one, three and seven days after either dorsal or plantar s.c CFA 
injection. Animals were habituated to the apparatus and experimenter 
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beginning 3 days prior to the start of the testing. Mechanical hyperalgesia: 
Serrated laboratory forceps were adapted with strain gauges for the 
measurement of the force applied across the tips (contact area 5.6mm2 per 
tip, total 11.2mm2, Supp. Figure 1).  The output signal was fed through a 
bridge amplifier and captured for subsequent offline analysis via a CED1401 
(Cambridge Electronic Design (CED), Cambridge UK) on a computer running 
Spike2 software (CED, Cambridge, UK). Grams per volt were calculated 
following calibration with standardised weights placed at the point of finger 
grip. The gram force delivered was then divided by the total contact area to 
give grams.mm-2. The tips were placed across the dorsoventral aspect of the 
hind paw and ramped pressure was applied until the foot was withdrawn or 
the animal displayed pain-related behaviours (vocalisation, biting etc.) at 
which point the force applied was immediately stopped. As the duration and 
force applied were controlled manually, and cut-off on first appearance of 
pain-related behaviours, the intensity of this stimulus could be controlled to 
ensure that it did not result in additional tissue damage. Use of this stimulator 
did not result in any observable tissue damage in naïve or inflamed animals. 
The occurrence of withdrawal/response was marked using the input from a 
foot pedal through the CED1401 into a computer running Spike2 software. 
Two consecutive recordings were made and mean threshold calculated for 
each animal at each time point.  
To test for thermal hyperalgesia a custom built Peltier heating device (contact 
area 18mm2) was used to deliver a ramped thermal stimulus to the hind paw 
of the rat from an initial contact temperature of 30oC. The maximum 
temperature was cut off at 55oC to prevent tissue damage. Surface (contact) 
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temperature was measured with a T-type thermocouple (made in-house) and 
captured for subsequent offline analysis via a CED1401 on a computer 
running Spike5 software. The extent of paw oedema was assessed by 
measuring the thickness across the midline dorsoventral aspect of the hind 
paw using callipers before, and 1 hour, 1, 3 and 7 days after CFA injection. 
Surgical preparation  
Surgical preparation for electromyograph recordings was performed under 
initial halothane anaesthesia (2-3% in O2) and consisted of; (i) external jugular 
branch cannulation for anaesthetic maintenance (constant intravenous 
infusion of alphaxalone (~40mg.kg.h; Alfaxan; Jurox Pty PLC, Australia)), (ii) 
external carotid artery branch cannulation for blood pressure measurement 
and (iii) tracheal cannulation for airway maintenance. Body temperature was 
maintained within physiological limits (37-38oC) by means of a feedback 
controlled heating blanket and rectal probe. For placement of the intrathecal 
catheter (Størkson et al., 1996), a longitudinal incision was made along the 
back midline, starting at the level of the iliac crest and advancing 2-3cm 
rostrally.  A 6cm length of 32G polyurethane catheter (OD: 0.25mm, ID: 
0.13mm ) with a manufacturer-supplied internal metal stylet for increased 
rigidity (Cat No: 0041; ReCathCo, USA) was back loaded into a 25G needle 
(Terumo Medical Corporation) so that the end of the catheter was flush with 
the needle tip. Animals were positioned with the vertebral column flexed and 
the catheter-loaded needle was inserted bevel up between L5 and L6 
vertebrae until a tail flick indicated penetration of dura. The catheter was then 
advanced ~3cm rostrally along the intrathecal space to approximately the 
level of the lumbar enlargement. The needle and stylet were then carefully 
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removed leaving the catheter in place, which was then fixed in position with 
cyanoacrylate glue (Superglue). A small (~2cm) length of polyethylene tubing 
(OD: 6.1mm, ID: 2.8mm) was then attached to the free end of the catheter, by 
insertion of the catheter end just into the polyethylene tubing, which was then 
secured with cyanoacrylate, to allow for connection to a Hamilton syringe for 
drug delivery.  
For the measurement of electromyographic (EMG) activity, a custom made bi-
polar electrode was made using Teflon coated stainless steel wires (0.075mm 
diameter; Advent research Materials, UK) that were stripped at both ends and 
one end inserted into the bicep femoris of the hind-leg using a 25-gauge 
hypodermic needle. The signal across the electrodes was amplified (x1K, 
Neurolog NL104 amplifier, A-B configuration; Digitimer, UK), filtered (50Hz-5 
KHz, Neurolog NL125) and raw data digitised via the CED1401, and stored 
for offline analysis using Spike2. Animals were left under a constant level of 
anaesthesia for a minimum of 1 hour after surgical preparation before further 
experiments. The level of anaesthesia was maintained by constant infusion 
such that EMG activity could be detected in response to stimulation without 
overt paw movement.  
Preferential activation of A- and C-heat nociceptors.    
A- and C-nociceptor were preferentially activated using a custom-made heat 
lamp in contact with the dorsal hind paw. A constant voltage was applied to 
the lamp to provide fast (7.5±1oC.s-1) or slow rates of heating (2.5±1oC.s-1), 
which preferentially activate A-fibre (myelinated, capsaicin-insensitive) and C-
fibre (unmyelinated, capsaicin-sensitive) heat nociceptors respectively 
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(Yeomans & Proudfit, 1996; McMullan et al., 2004; McMullan & Lumb, 2006a; 
Leith et al., 2007). Stimuli were applied with an inter-stimulus interval of at 
least 8 minutes to prevent tissue damage and sensitisation. The heat ramp 
apparatus was placed in contact with the foot for a minimum of 60 seconds 
before the start of the heat stimulation to allow for the adaptation for low 
threshold mechanoreceptors. A feedback-controlled cut-off was set at 58oC 
for fast thermal ramps and 55oC for slow thermal ramps to prevent tissue 
damage. In recordings in which thermal ramps reached the cut-off 
temperature without the occurrence of measurable EMG activity, threshold 
was recorded as cut-off + 2oC (Leith et al., 2007). For stimulation of glabrous 
skin, a slow ramp (2.5±1oC.s-1) contact heat stimulus was applied immediately 
behind the foot-pad using the same apparatus. As it has not yet been 
determined whether this stimulus is able to preferentially activate A- or C-
nociceptors in glabrous skin no attempt was made to draw conclusions with 
respects to A- or C-nociceptor activation at this site. 
Subsurface heating rate measurement   
To determine whether CFA-induced paw oedema affected the subcutaneous 
heating rates that are required for preferential activation of A- and C-
nociceptors, subcutaneous heating rates were directly measured using a T-
type thermocouple. Heating rates were recorded before, for three hours and 
on the seventh day after s.c. CFA injection. Care was taken to implant the 
thermocouple as close to the dermal/epidermal border as possible as 
nociceptive terminals are found in epidermis and superficial dermal layers. 
Two ramps were delivered at each experimental time point. 
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Drugs   
The alpha-2-adrenoreceptor antagonist yohimbine 30µg in 10µl in vehicle 
(80% saline/20%DMSO), Cat no: 1127 Tocris Biosciences, Bristol, UK) was 
delivered intrathecally via the implanted catheter 2.5h after CFA (n=9) so that 
the peak drug effect coincided with the third hour following CFA. The 
concentration of yohimbine used was based on previous reports of effective 
intrathecal alpha-2 adrenoceptor blockade (Ossipov et al., 1989; Takano & 
Yaksh, 1992; Green et al., 1998).  At the time of injection the tip of a 100µl 
Hamilton syringe was inserted in to the PE10 tubing and 10µl of the drug was 
delivered over several minutes. This was washed through with an equivalent 
volume of saline. In a separate group of animals (n=6) the non-specific opioid 
antagonist naloxone (3mg.kg-1 in 0.9%saline) (Sigma-Aldrich, UK, Cat no: 
N7758) was delivered intraperitoneally so that the peak drug effect coincided 
with the second hour following CFA. 
At the end of the experiment the position of the cannula was determined by 
injecting 20µl of Xylocaine (2%) through the cannula. If pinch-evoked EMG 
activity was abolished the cannula was deemed to be correctly positioned, if 
not the data were not included in subsequent analyses (n=1, CFA injected). 
Additionally, in some experiments the location of the distal tip of the catheter 
was determined by injection of pontamine Sky Blue (20µl of 5%) and visual 
confirmation of the location of the catheter tip. 
Statistical analyses  
Data are displayed as mean + SEM unless otherwise noted in Figure legends. 
Data were analysed using Graphpad Prism v4/5 using Mann Whitney test (2 
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group comparisons) or Kruskal-Wallis, one- or two-way ANOVA (3 or more 
groups) where appropriate and as stated in Figure legends. *p<0.05, 
**p<0.01, ***p<0.001, ****p<0.0001. 
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Results 
Consequences of CFA induced inflammation of the hairy skin of the rat hind 
paw.  
Injection of 50µg CFA into the hind-paw dorsum resulted in paw oedema that 
was evident after one hour and persisted for 7 days (Figure 1A; baseline: 
4.2±0.1mm vs seven days: 6.3±0.2mm, p<0.001). CFA also produced a 
mechanical hyperalgesia to a noxious pinch (Figure 1B; baseline 87±33g.mm-
2
 vs. seven days 39±5g.mm-2, p<0.05) but did not induce a thermal 
hyperalgesia in hairy skin (Figure 1C; baseline 49±1.1oC, three hours 
49±2.3oC, twenty-four hours 47±1.3oC and three days 51±1.0oC). An 
equivalent subcutaneous injection of CFA into the plantar surface of the hind-
paw resulted in thermal hyperalgesia that persisted for at least three days 
(Figure 1D, baseline 47±0.9 oC vs. three days 42±1.2oC, p<0.05).  
The ability of the thermal ramp stimuli to preferentially activate A- and C- 
nociceptors is reliant on achieving subsurface cutaneous heating rates of 
2.5oC.s-1 (fast) for A-nociceptors and 0.8oC.s-1 (slow) for C-nociceptors 
(Yeomans & Proudfit, 1996; McMullan et al., 2004; McMullan & Lumb, 2006a; 
Leith et al., 2007). As paw oedema could affect the heat transfer through the 
skin, and thus subcutaneous heating rates, we first determined the effect of 
acute inflammatory oedema on cutaneous heating rates.  Surface heating 
rates elicited by both fast and slow heating ramps were kept within limits 
previously shown to elicit correct subsurface heating rates in normal skin 
(Fast - 7.5 oC.s-1, Slow - 2.5 oC.s-1; McMullan et al., 2004) and the 
corresponding subsurface heating rates were recorded.  Subsurface heating 
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rates to both fast and slow thermal ramps were unchanged over the three 
hours of acute inflammation (Supp. Figure 2, p>0.05). However, at seven 
days following CFA, subsurface heating rates elicited by slow thermal ramps 
were significantly faster than pre-CFA values (Suppl. Figure 2B; baseline 
subsurface rate 0.6 ± 0.03oC.s-1 vs. seven day subsurface rate 1.2 ± 0.1oC.s-1; 
p<0.05). 
Effect of CFA induced inflammation on the spinal processing of thermal 
nociceptor inputs from hairy and glabrous skin.   
We sought to determine the effects of CFA induced inflammation of hairy skin 
on the spinal processing of A- and C-nociceptor inputs. Withdrawal thresholds 
to thermal A- and C-nociceptor stimulation were both significantly lower one 
hour after CFA injection (Figure 2A; baseline A-nociceptors vs. one hour A-
nociceptors, 57 ± 0.8oC vs. 45 ± 0.9oC, p<0.001) (Figure 2B; baseline C-
nociceptors vs. one hour C-nociceptors, 53 ± 0.4oC vs. 40 ± 1.8oC, p<0.001). 
After 2 hours, withdrawal threshold to C-nociceptor stimulation had returned to 
slightly above baseline levels (Figure 2B; baseline vs. two hours, 53 ± 0.4oC 
vs. 54 ± 2.0oC) whereas A nociceptor thresholds were still lowered (Fig 2A; 
baseline vs. two hour, 57 ± 0.8oC vs. 49 ± 2.0oC, p<0.001). By three hours A 
and C nociceptor thresholds had returned to baseline values (Figure 2A & B, 
p>0.05). Vehicle injection had no significant effect on A- or C-nociceptor 
thresholds (Fig 2A & B; p>0.05). It should be noted that in three of five 
animals, at two and three hours following CFA, no EMG activity to C-
nociceptor stimulation was evoked before stimulation reached the imposed 
cut-off temperature. Furthermore, in two additional animals (data not 
used/shown in further analysis) the cut-off was not imposed and in these 
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animals we found thresholds for withdrawal to C-nociceptor activation to be 
greater than 60oC. In contrast thresholds of withdrawal to A-nociceptor 
activation where always below the imposed temperature cut-off.  
Doubling the amount of injected CFA resulted in significantly less sensitisation 
of the reflex pathway over the three hour period (Figure 2C & D). Compared 
to the 50µg dose, a 100µg CFA injection caused similar reduction in A-
nociceptor withdrawal threshold at one hour, but surprisingly significantly less 
of a reduction in C-nociceptor threshold at this time (Figure 2D; 50µg at 1h vs. 
100µg at 1h, 40 ± 1.8oC vs. 51 ± 1.0oC, p<0.001). At two hours, both C- and 
A-nociceptor withdrawal threshold had return to baseline values and A-
nociceptor withdrawal thresholds were significantly higher when compared to 
threshold values for the 50µg dose at the same time point (Figure 2C; 50µl at 
two hour vs. 100µl at two hour, 49 ± 2.0oC vs 55 ± 1.4oC, p<0.05).   
Although CFA is known to produce persistent afferent sensitisation lasting 
days/weeks (Ren & Dubner, 1999), following dorsal CFA we found thermal 
nociceptive behaviour to be unchanged at 3 days (Figure 1). Additionally, 
seven days after CFA injection, withdrawal thresholds to A- and C-nociceptor 
activation were also unchanged (C-nociceptor naïve vs. C-nociceptor seven 
day CFA, 53 ± 0.6oC. vs. 55 ± 2.0oC; Mann-Whitney p>0.05, n=4; A-
nociceptor naïve vs. A-nociceptor seven day CFA, 58 ± 0.5oC vs. 58 ± 0.6oC; 
Mann-Whitney p>0.05, n=4, not shown). In contrast, although the withdrawal 
threshold did increase slightly towards baseline over three hours, injection of 
CFA into the glabrous skin of the plantar hind-paw resulted in a significant 
reduction in withdrawal thresholds to the thermal stimulus for the three hours 
studied (Figure 3 - p<0.05 at all time points). It has been previously shown 
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that s.c. CFA delivered to the plantar surface of the paw leads to thermal 
hyperalgesia lasting more than one week (Ren & Dubner, 1999). Differences 
in sensitisation might be attributable to differences in inflammatory reaction 
and/or oedema. There was significantly greater swelling in the plantar surface 
of the hindpaw 3 h after injection of CFA compared to the dorsal surface 
(Figure 4. 3h dorsal 5.9±0.2mm n=7; plantar 6.9±0.2mm, n=6, p<0.05). The 
degree of swelling of the hindpaw was not significantly different after injection 
of 100µg CFA, compared with 50µg CFA injected into the dorsal surface 
(Figure 4, 3h 100µg dorsal 6±0.2mm, n=5).  
 
Effect of spinal alpha-2-adrenoceptor receptor blockade on the processing of 
thermal nociceptor inputs during hind paw inflammation.   
Following inflammation of hairy skin the observation of sensitisation followed 
by a reversal over minutes/hours suggested that descending inhibitory 
mechanisms could be affecting spinal processing in acute inflammation. 
Intrathecal delivery of the alpha-2-adrenoceptor antagonist, yohimbine (30µg 
in 10µl) (Takano & Yaksh, 1992; Green et al., 1998; Hughes et al., 2013), 2 
hours after CFA, when thresholds had returned (C-nociceptors) or were 
returning to baseline (A-nociceptors), significantly inhibited the reversal of 
both A- and C-nociceptor withdrawal thresholds (Figure 5A; 3 hour A-
nociceptor CFA only vs. 3 hour A-nociceptor CFA+yohimbine, 55 ± 1.3oC vs. 
50 ± 0.9oC, p<0.05) (Figure 5B; 3 hour C-nociceptor CFA only vs. 3 hour C-
nociceptor CFA+yohimbine, 55 ± 1.1oC vs. 47 ± 2.3oC, p<0.05). In contrast, 
yohimbine did not affect the withdrawal to thermal stimulation applied to 
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inflamed glabrous skin (Figure 3), which was apparent at 1 hour, and 
maintained for the 3 hours studied (Figure 3; CFA only 3h threshold vs. 
CFA+yohimbine 3h withdrawal threshold, 47 ± 0.7oC vs. 47 ± 0.4oC). 
Intrathecal delivery of the same volume of vehicle did not affect withdrawal 
thresholds in either experiment (n=3 for both experiments, data not shown).   
Spinal and supraspinal opioidergic systems are known to have robust 
inhibitory effects on spinal nociceptive processing during inflammation (Stanfa 
& Dickenson, 1995; Przewłocki & Przewłocka, 2001). We therefore also 
determined the contribution of opioidergic systems to the degree of 
hyperalgesia in acute hind paw CFA inflammation. Systemic delivery of the 
pan-opioid receptor antagonist naloxone (3mg.kg-1 (Stanfa & Dickenson, 
1995)) had no effect on either A- or C-nociceptor withdrawal thresholds in 
hairy skin at either 2 or 3 hours following CFA (Figure 5C + D).  It has been 
previously shown that naloxone has no effect on withdrawal latencies to 
thermal stimuli at 4 hours following plantar inflammation (Hylden et al., 1991; 
Tsuruoka & Willis, 1996). 
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Discussion  
 
Two key observations arise from these data; (i) there is a differential 
descending noradrenergic inhibitory control on different skin types in acute 
inflammation, and (ii) there is a greater descending inhibitory control of C- 
compared to A-nociceptor evoked reflexes from hairy skin.  
Subcutaneous injection of CFA is a well characterised and widely used 
cutaneous inflammatory model, primarily used to study inflammatory 
hypersensitivity in glabrous (plantar) skin (Iadarola et al., 1988; Ren & 
Dubner, 1999). The oedema generated in glabrous or hairy skin is not 
equivalent for the same dose of CFA (data herein, (Cook & Moore, 2006)), but 
as CFA produces a dose-dependent inflammatory response (Donaldson et al., 
1993) that should be equivalent at different sites, inflammation of hairy and 
glabrous skin might be predicted to induce equivalent primary hyperalgesia. 
Literature reports that CFA injection results in a robust primary mechanical 
and, usually, following plantar injection, thermal behavioural hypersensitivity 
to stimulation from as early as one hour and reportedly lasting for weeks 
(Iadarola et al., 1988; Ren & Dubner, 1999; Terayama et al., 2002; Soignier et 
al., 2011). Plantar inflammation also results in mechanical hypersensitivity 
(data herein, (Ren & Dubner, 1999; Cook & Moore, 2006; Soignier et al., 
2011). In contrast, dorsal (hairy) hindpaw inflammation results in no change in 
thermal reflex withdrawal response, despite thermal sensitisation of single 
peripheral nociceptors in the same model (Dunham et al., 2008; Koerber et 
al., 2010). CFA induced inflammation results in robust long-lasting peripheral 
nociceptor thermal sensitisation, in rats, guinea pigs and primates, (Kocher et 
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al., 1987; Davis et al., 1993; Andrew & Greenspan, 1999; Djouhri & Lawson, 
1999; Djouhri et al., 2001; Dunham et al., 2008; Koerber et al., 2010) 
irrespective of whether hairy or glabrous skin is inflamed, which is inconsistent 
with the behavioural data. We therefore determined whether the observed 
lack of thermal behavioural responses in acute inflammation might be 
attributable to descending inhibitory control of nociceptive processing from 
inflamed hairy skin sites. The observation that plantar inflammation produces 
greater swelling, but little obvious descending inhibition, whereas dorsal 
inflammation produces less swelling but more profound inhibition with 
increasing inflammatory severity, suggest that it is the overall degree of 
inflammation, rather than just the oedema, that engages descending control 
systems. This is consistent with previous findings, where much higher CFA 
doses produced acute thermal analgesia i.e. less nociception than control, in 
hairy but not glabrous skin (Cook & Moore, 2006). Differences in inflammatory 
oedema in different sites may not therefore accurately predict nociceptive 
responses, as this aspect of inflammation may more accurately reflect local 
tissue compliance (Reed & Rubin, 2010) rather than nociceptive input.  
Processing of noxious inputs is known to be subject to both descending 
inhibitory and facilitatory controls (Millan, 2002; Vanegas & Schaible, 2004). 
Primary inflammatory hyperalgesia is widely accepted to be dominated by 
descending inhibitory controls, which are both rapidly activated and long-
lasting. These are hypothesised to protect against spinal hyperexcitabilty 
following inflammation by limiting mechanisms of central sensitisation (Ren & 
Dubner, 1996; Vanegas & Schaible, 2004). However, they are not usually 
reported to completely obliterate the nociceptive sensitivity resulting from the 
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insult (Tsuruoka & Willis, 1996; Tsuruoka et al., 2003; Vanegas & Schaible, 
2004). This is in contrast to our findings where thermal hyperalgesia in hairy 
skin was more short lived, particularly so when inflammation was more severe 
(100µg CFA dose).  
Descending fibres from areas such as LC and RVM exert profound 
modulatory influences on spinal nociceptive processing (Fields et al., 1991; 
Tsuruoka & Willis, 1996; Miki et al., 2002; Millan, 2002; Tsuruoka et al., 2003) 
through monoaminergic systems (Pertovaara, 2006; Yoshimura & Furue, 
2006). Descending monoaminergic systems, particularly noradrenaline acting 
through spinal alpha-2 receptors, are reported to modulate the development 
of inflammatory hyperalgesia (Tsuruoka & Willis, 1996; Tsuruoka et al., 2003; 
Pertovaara, 2006). Our findings confirm this for hairy cutaneous tissue, and 
additionally indicate that, at acute time points, yohimbine blockade 
differentially modulates thermal inflammatory sensitivity in hairy/glabrous skin.  
It has been proposed that the descending noradrenergic systems form a 
stimulus driven negative feedback circuit that impinges onto spinal nociceptive 
processing and so regulates the onward flow of ascending nociceptive 
information (Pertovaara, 2006, 2013). In hairy skin, our finding of a greater 
inhibition in more severe inflammation would support this. In contrast, in 
glabrous skin hypersensitivity persists (>4h) (Tsuruoka & Willis, 1996) and at 
acute time points (<3h) we find little evidence of either monoaminergic or 
opioidergic inhibition, consistent with previous findings (Hylden et al., 1991; 
Tsuruoka & Willis, 1996). 
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Although yohimbine has high affinity for alpha-2 receptors and is commonly 
used as a specific alpha-2-adrenoceptor antagonist, it has moderate affinity at 
alpha-1-adrenoceptors, 5-HT1A, 5-HT1B and dopamine D2 receptors (Ki 
determinations generously provided by the National Institute of Mental 
Health’s Psychoactive Drug Screening Program, 
(http://pdsp.med.unc.edu/pdsp.php)). As a result of the latter effects, systemic 
yohimbine can decrease 5-HT and increase dopamine and noradrenaline 
levels in rat CNS, probably through blockade of autoreceptors (Paalzow & 
Paalzow, 1983; Millan et al., 2000). In inflammation, spinal 5-HT1A receptors 
both enhance (Zhang et al., 2001; Wang et al., 2003) and inhibit (Liu et al., 
2002; Yu et al., 2011; Horiguchi et al., 2013) acute inflammatory nociception; 
known descending 5-HT3 receptor-mediated facilitatory pathways do not 
seem to contribute to inflammatory nociception (Asante & Dickenson, 2010). 
There are no published data on contributions of spinal D2 receptors to acute 
inflammatory nociception. Although this concentration of yohimbine 
administered intrathecally has been widely interpreted as exerting actions 
primarily at alpha-2 adrenoceptors (Ossipov et al., 1989; Takano & Yaksh, 
1992; Green et al., 1998; De Felice et al., 2011; Little et al., 2012; Hughes et 
al., 2013), we cannot exclude an additional contribution of modulation of 
alpha-1-adreno or 5-HT
 
receptors at the spinal level to the observed effects of 
yohimbine. Actions of yohimbine on 5-HT1A receptors would be consistent 
with a concurrent anti-nociceptive effect of 5-HT in this model (Liu et al., 2002; 
Yu et al., 2011; Horiguchi et al., 2013).  
The nocifensive flexor reflex is thought to provide an objective measure of 
noxious threshold and is the most commonly used in pain studies in both 
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humans and animals (Wiesenfeld-Hallin, 1995; Sandrini et al., 2005). In 
animals the nocifensive flexor reflex typically involves recording 
electromyographic activity from the biceps femoris evoked by stimulation of 
the hind-paw (Wiesenfeld-Hallin, 1995), alpha motor neurons serving the 
biceps femoris have receptive fields on both the dorsal and plantar surface 
(Cook & Woolf, 1985), thus the effects of drugs on reflexes evoked from both 
paw surfaces can be directly compared and contrasted. Thus, whilst the 
musculotopic organisation of reflexes may have meant that recording from 
different muscular sites may have yielded slightly different results 
(Schouenborg et al., 1994; Harris & Clarke, 2002), these may not have been 
directly comparable for stimulation of different sites on the hindpaw. In 
addition, as alpha-2-adrenoceptor agonists are analgesic (Pertovaara, 2006) 
and presumably inhibit the sensory afferent arm of the withdrawal reflex, it 
could be hypothesised that the result of yohimbine blockade would affect, to a 
greater or lesser extent, all muscle groups involved in noxious withdrawal 
reflexes. This is supported by the behavioural data.  
A differential descending inhibitory control on glabrous versus hairy skin may 
relate to the functional importance of the footpad/glabrous skin. The plantar 
surface forms the main exploratory hindpaw surface in rodents, providing 
important sensory/discriminative information about the environment (Boada et 
al., 2013). Pain provides a critical protective mechanism in which nociceptive 
sensitisation, including increased reflex sensitivity, serves to protect injured 
areas that might regularly come into contact with physical stimuli 
(Schouenborg et al., 1994) and it has been shown that load bearing parts of 
the paw have special significance in generating reflex sensitisation (Clarke & 
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Harris, 2004). However, effective locomotion is essential to survival, being 
central to feeding and escape behaviours, and therefore the positive impact of 
nociceptive reflex hypersensitivity and its protective function must be traded 
off against its negative impact on locomotion. Thus peripheral domains that 
rarely come into contact with nociceptive stimuli (dorsal hind-paw) may have a 
reduced capacity to produce reflex sensitisation following inflammation.  
The differences in descending inhibition of spinal processing of afferent input 
from different peripheral domains may also represent a difference in both 
innervation and the effects of inflammation on innervating neuronal properties. 
The inflammatory sensitisation of unmyelinated afferents differs in glabrous 
versus hairy skin in both rat and primate (Campbell & Meyer, 1983; Kocher et 
al., 1987; Andrew & Greenspan, 1999; Dunham et al., 2008), in that 
peripheral thermal sensitisation occurs in C-nociceptors innervating hairy skin 
(Campbell & Meyer, 1983; Davis et al., 1993; Dunham et al., 2008; Koerber et 
al., 2010), but not in glabrous skin (Meyer & Campbell, 1981; Campbell & 
Meyer, 1983; Andrew & Greenspan, 1999; Du et al., 2006), where C-
nociceptors may become desensitised instead (Campbell & Meyer, 1983; 
Andrew & Greenspan, 1999). C-nociceptors play critical roles in driving 
mechanisms of central sensitisation and of descending controls from 
supraspinal sites (Woolf & Wall, 1986; Sivilotti et al., 1993; Suzuki et al., 2002; 
Ikeda et al., 2003; Mantyh & Hunt, 2004; You et al., 2010). Sensitisation of C-
nociceptors in inflamed hairy skin would drive ascending, and therefore also 
descending systems to a greater extent than in glabrous skin, where C-
nociceptors do not readily sensitise, leading to the differences in inhibition 
observed. This is supported by the enhanced inhibition seen in a more severe 
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inflammation where nociceptors would be sensitised more rapidly and afferent 
barrage would be greater (Figure 3 A & B).  
Previous findings from our laboratory indicate that descending inhibitory 
controls, arising from the PAG preferentially target C-nociceptive inputs to 
spinal nociceptive networks (McMullan & Lumb, 2006b). Here, during acute 
inflammation of hairy skin, we observe a fast acting and potent inhibition of C-
nociceptor evoked withdrawals; at two and three hours following CFA the 
withdrawal thresholds to C-nociceptor stimulation were greater than baseline 
values and in 3/5 animals we observed no evoked EMG activity before the 
cut-off temperature was reached. Additionally, in the two cases where the cut-
off was removed, thresholds for EMG activity were greater than 60oC (data 
not shown). In contrast, at two hours following CFA, thresholds for A-
nociceptor evoked withdrawals were still significantly lower than baseline 
values and, at three hours following CFA, all 5 animals responded to the 
thermal stimuli before the cut-off temperature was reached. It is likely that the 
effect of yohimbine on C- versus A-nociceptor evoked withdrawals failed to 
reach significance (data not shown) as a result of the inherent 
underestimation of the full effect of yohimbine on C-nociceptor withdrawal 
thresholds due to the imposed temperature cut-off (55oC). Descending 
inhibitory systems have been shown to preferentially target thermal spinal 
nociceptive processing in both normal and inflamed rats (Kauppila et al., 
1998; Howorth et al., 2009), consistent with our observations. Additionally, as 
noxious mechanical stimuli are thought to be conveyed by A-fibre nociceptors 
(Ziegler et al., 1999; Magerl et al., 2001) an alternative interpretation of these 
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findings is that there as a preferential inhibition of spinal nociceptive 
processing of C- versus A-nociceptor inputs.     
There may be a possible evolutionary advantage of greater inhibitory control 
on C- compared to A-nociceptor-evoked reflexes which could relate to the 
different functions of these afferents. In humans, rapidly conducting A-
nociceptors convey sharp, well localised painful sensations (Magerl et al., 
2001), information which is encoded with a high fidelity by spinal neurons (rat) 
(McMullan & Lumb, 2006a).  In contrast, slowly conducting C-nociceptors 
convey dull and diffuse pain (Ziegler et al., 1999; Magerl et al., 2001) encoded 
with low fidelity by spinal neurons in rats (McMullan & Lumb, 2006a). Thus A-
nociceptors are hypothesised to convey more detailed information relating to 
the protective function of pain, i.e. localisation and magnitude assessment. A 
greater acute inhibition of C-nociceptor inputs could serve to filter extraneous 
C-nociceptive information and limit saturation in the reflex pathway (Tsuruoka 
et al., 2012) while concurrently preserving A-nociceptive information which is 
essential to the protective function of reflex withdrawals. Thus differential 
inhibitory control of inputs from body areas with different functions, and from 
different nociceptor types would be hypothesised to limit central sensitisation 
and protect against spinal hyperexcitabilty following inflammation, whilst 
maintaining adequate locomotor and protective nociceptive function to enable 
healing/survival.  
 
 
  
Differential descending control of inputs from hairy vs. glabrous skin 
 
 
29
Competing interests:  
The authors have no competing interests to declare.  
Author’s contributions:  
Experiments were performed in laboratories in the School of Physiology and 
Pharmacology, University of Bristol. RARD, BML & LFD contributed to 
experimental design, and data analysis and interpretation, RPH designed and 
built the mechanical stimulator, RARD contributed data collection, RARD, 
BML & LFD wrote the manuscript, and all authors approved final manuscript 
submission.  
Funding 
This work was funded by the Medical Research Council (DTP studentship 
supporting RARD, Project grant G0801381 (BML)) and a BBSRC/MRC/BPS 
Strategic Skills award (LFD & BML).  
Acknowledgements:  
We would like to thank Prof. Bruce Matthews for assistance with the design 
and build of the mechanical pincher, and additionally Dr. Louise Hickey and 
Mr Sam Hughes for their helpful discussions and input on technical issues.  
Supporting information 
The online supporting information gives further detail on the mechanical 
stimulation device, and the validation of the heat ramp stimulations in inflamed 
skin.  
 
 
 
 
Differential descending control of inputs from hairy vs. glabrous skin 
 
 
30
 
 
 
 
 
 
 
References: 
Andrew D & Greenspan J (1999). Mechanical and heat sensitization of cutaneous 
nociceptors after peripheral inflammation in the rat. J Neurophysiol 82, 2649–
2656. 
Asante CO & Dickenson AH (2010). Descending serotonergic facilitation mediated by 
spinal 5-HT3 receptors engages spinal rapamycin-sensitive pathways in the rat. 
Neurosci Lett 484, 108–112. 
Bajic D & Proudfit HK (1999). Projections of neurons in the periaqueductal gray to 
pontine and medullary catecholamine cell groups involved in the modulation of 
nociception. J Comp Neurol 405, 359–379. 
Blake DT, Byl NN & Merzenich MM (2002). Representation of the hand in the 
cerebral cortex. Behav Brain Res 135, 179–184. 
Boada MD, Houle TT, Eisenach JC & Ririe DG (2013). Differing neurophysiologic 
mechanosensory input from glabrous and hairy skin in juvenile rats differing 
neurophysiologic mechanosensory input from glabrous and hairy skin in juvenile 
rats. J Neurophysiol 104, 3568–3575. 
Campbell JN & Meyer RA (1983). Sensitization of unmyelinated nociceptive afferents 
in monkey varies with skin type. J Neurophysiol 49, 98–110. 
Chillingworth NL, Morham SG, Donaldson LF (2006). Sex differences in inflammation 
and inflammatory pain in cyclooxygenase-deficient mice. Am J Physiol Regul 
Integr Comp Physiol 291, 327–334. 
Clarke RW & Harris J (2004). The organization of motor responses to noxious 
stimuli. Brain Res Brain Res Rev 46, 163–172. 
Cook AJ & Woolf CJ (1985). Cutaneous receptive field and morphological properties 
of hamstring flexor α-motorneurones in the rat. J Physiol 364, 249–263. 
Cook CD & Moore KI (2006). Effects of sex, hindpaw injection site and stimulus 
modality on nociceptive sensitivity in arthritic rats. Physiol Behav 87, 552–562. 
Differential descending control of inputs from hairy vs. glabrous skin 
 
 
31
Davis KD, Meyer RA & Campbell JN (1993). Chemosensitivity and sensitization of 
nociceptive afferents that innervate the hairy skin of monkey. J Neurophysiol 69, 
1071–1081. 
Djouhri L, Dawbarn D, Robertson A, Newton R & Lawson SN (2001). Time course 
and nerve growth factor dependence of inflammation-induced alterations in 
electrophysiological membrane properties in nociceptive primary afferent 
neurons. J Neurosci 21, 8722–8733. 
Djouhri L & Lawson SN (1999). Changes in somatic action potential shape in guinea-
pig nociceptive primary afferent neurones during inflammation in vivo. J Physiol 
520, 565–576. 
Dogrul A, Ossipov MH & Porreca F (2009). Differential mediation of descending pain 
facilitation and inhibition by spinal 5HT-3 and 5HT-7 receptors. Brain Res 1280, 
52–59. 
Donaldson LF, Seckl JR & McQueen DS (1993). A discrete adjuvant-induced 
monoarthritis in the rat: effects of adjuvant dose. J Neurosci Methods 49, 5–10. 
Du J, Zhou S & Carlton SM (2006). Kainate-induced excitation and sensitization of 
nociceptors in normal and inflamed rat glabrous skin. Neuroscience 137, 999–
1013. 
Dunham JP, Kelly S & Donaldson LF (2008). Inflammation reduces mechanical 
thresholds in a population of transient receptor potential channel A1-expressing 
nociceptors in the rat. Eur J Neurosci 27, 3151–3160. 
Fields HL, Heinricher MM & Mason P (1991). Neurotransmitters in nociceptive 
modulatory circuits. Annu Rev Neurosci 14, 219–245. 
Green GM, Lyons L & Dickenson AH (1998). Alpha2-adrenoceptor antagonists 
enhance responses of dorsal horn neurones to formalin induced inflammation. 
Eur J Pharmacol 347, 201–204. 
Guan Y, Terayama R, Dubner R & Ren K (2002). Plasticity in excitatory amino acid 
receptor-mediated descending pain modulation after inflammation. J Pharmacol 
Exp Ther 300, 513–520. 
Harris J & Clarke RW (2002). Organisation of sensitisation of hind limb withdrawal 
reflexes from acute noxious stimuli in the rabbit. J Physiol 546, 251–265. 
Horiguchi N, Ago Y, Hasebe S, Higashino K, Asada K, Kita Y, Takuma K & Matsuda 
T (2013). Isolation rearing reduces mechanical allodynia in a mouse model of 
chronic inflammatory pain. Pharmacol Biochem Behav 113, 46–52. 
Howorth PW, Thornton SR, O’Brien V, Smith WD, Nikiforova N, Teschemacher AG & 
Pickering AE (2009). Retrograde viral vector-mediated inhibition of pontospinal 
noradrenergic neurons causes hyperalgesia in rats. J Neurosci 29, 12855–
12864. 
Hughes SW, Hickey L, Hulse RP, Lumb BM & Pickering AE (2013). Endogenous 
analgesic action of the pontospinal noradrenergic system spatially restricts and 
Differential descending control of inputs from hairy vs. glabrous skin 
 
 
32
temporally delays the progression of neuropathic pain following tibial nerve 
injury. Pain 154, 1680–1690. 
Hylden J, Thomas D, Iadarola M, Nahin R & Dubner R (1991). Spinal opioid 
analgesic effects are enhanced in a model of unilateral 
inflammation/hyperalgesia: possible involvement of noradrenergic mechanisms. 
Eur J Pharmacol 194, 135–143. 
Iadarola M, Brady L, Draisci G & Dubner R (1988). Enhancement of dynorphin gene 
expression in spinal cord following experimental inflammation: stimulus 
specificity, behavioral parameters and opioid receptor binding. Pain 35, 313–
326. 
Ikeda H, Heinke B, Ruscheweyh R & Sandkühler J (2003). Synaptic plasticity in 
spinal lamina I projection neurons that mediate hyperalgesia. Science 299, 
1237–1240. 
Jeong H-J, Mitchell V a & Vaughan CW (2012). Role of 5-HT1 receptor subtypes in 
the modulation of pain and synaptic transmission in rat spinal superficial dorsal 
horn. Br J Pharmacol 165, 1956–1965. 
Kauppila T, Kontinen VK & Pertovaara A (1998). Influence of spinalization on spinal 
withdrawal reflex responses varies depending on the submodality of the test 
stimulus and the experimental pathophysiological condition in the rat. Brain Res 
797, 234–242. 
Kocher L, Anton F, Reeh P & Handwerker H (1987). The effect of carrageenan-
induced inflammation on the sensitivity of unmyelinated skin nociceptors in the 
rat. Pain 29, 363–373. 
Koerber HR, McIlwrath SL, Lawson JJ, Malin SA, Anderson CE, Jankowski MP & 
Davis BM (2010). Cutaneous C-polymodal fibers lacking TRPV1 are sensitized 
to heat following inflammation, but fail to drive heat hyperalgesia in the absence 
of TPV1 containing C-heat fibers. Mol Pain 6, 58. 
Latremoliere A & Woolf CJ (2009). Central sensitization: a generator of pain 
hypersensitivity by central neural plasticity. J Pain 10, 895–926. 
Leem JW, Willis WD & Chung JM (1993). Cutaneous sensory receptors in the rat 
foot. J Neurophysiol 69, 1684–1699. 
Leith JL, Wilson AW, Donaldson LF & Lumb BM (2007). Cyclooxygenase-1-derived 
prostaglandins in the periaqueductal gray differentially control C- versus A-fiber-
evoked spinal nociception. J Neurosci 27, 11296–11305. 
Liu Z-Y, Zhuang D-B, Lunderberg T & Yu L-C (2002). Involvement of 5-
hydroxytryptamine(1A) receptors in the descending anti-nociceptive pathway 
from periaqueductal gray to the spinal dorsal horn in intact rats, rats with nerve 
injury and rats with inflammation. Neuroscience 112, 399–407. 
Lynn B & Carpenter S (1982). Primary afferent units from the hairy skin of the rat 
hind limb. Brain Res 238, 29–43. 
Differential descending control of inputs from hairy vs. glabrous skin 
 
 
33
Magerl W, Fuchs PN, Meyer RA & Treede RD (2001). Roles of capsaicin-insensitive 
nociceptors in cutaneous pain and secondary hyperalgesia. Brain 124, 1754–
1764. 
Mantyh PW (1983). Connections of midbrain periaqueductal gray in the monkey. II. 
Descending efferent projections. J Neurophysiol 49, 582–594. 
Mantyh PW & Hunt SP (2004). Setting the tone: superficial dorsal horn projection 
neurons regulate pain sensitivity. Trends Neurosci 27, 582–584. 
McMullan S & Lumb BM (2006a). Spinal dorsal horn neuronal responses to 
myelinated versus unmyelinated heat nociceptors and their modulation by 
activation of the periaqueductal grey in the rat. J Physiol 576, 547–556. 
McMullan S & Lumb BM (2006b). Midbrain control of spinal nociception discriminates 
between responses evoked by myelinated and unmyelinated heat nociceptors in 
the rat. Pain 124, 59–68. 
McMullan S & Lumb BM (2006c). Spinal dorsal horn neuronal responses to 
myelinated versus unmyelinated heat nociceptors and their modulation by 
activation of the periaqueductal grey in the rat. J Physiol 576, 547–556. 
McMullan S, Simpson DA & Lumb BM (2004). A reliable method for the preferential 
activation of C- or A-fibre heat nociceptors. J Neurosci Methods 138, 133–139. 
Meyer RA & Campbell JN (1981). Myelinated nociceptive afferents account for the 
hyperalgesia that follows a burn to the hand. Science 213, 1527–1529. 
Meyer RA, Ringkamp M, Campbell JN & Raja SN (2005). Neural mechanisms of 
hyperalgesia after tissue injury. Johns Hopkins APL Tech Dig 26, 56–66. 
Miki K, Zhou QQ, Guo W, Guan Y, Terayama R, Dubner R & Ren K (2002). Changes 
in gene expression and neuronal phenotype in brain stem pain modulatory 
circuitry after inflammation. J Neurophysiol 87, 750–760. 
Millan MJ (2002). Descending control of pain. Prog Neurobiol 66, 355–474. 
Millan MJ, Newman-Tancredi A, Audinot V, Cussac D, Lejeune F, Nicolas J, Coge F, 
Galizzi J, Boutin J, Rivet J, A D & Gobert A (2000). Agonist and antagonist 
actions of yohimbine as compared to fluparoxan at alpha(2)-adrenergic 
receptors (AR)s, serotonin (5-HT)(1A), 5-HT(1B), 5-HT(1D) and dopamine D(2) 
and D(3) receptors. Significance for the modulation of frontocortical 
monoaminergic transmission and depressive states. Synapse 35, 79–95. 
Oliva P, Berrino L, de Novellis V, Palazzo E, Marabese I, Siniscalco D, Scafuro M, 
Mariani L, Rossi F & Maione S (2006). Role of periaqueductal grey 
prostaglandin receptors in formalin-induced hyperalgesia. Eur J Pharmacol 530, 
40–47. 
Ossipov MH, Dussor GO & Porreca F (2010). Central modulation of pain. J Clin 
Invest 120, 3779–3787. 
Differential descending control of inputs from hairy vs. glabrous skin 
 
 
34
Ossipov MH, Suarez LJ & Spaulding TC (1989). Antinociceptive interactions between 
alpha , -adrenergic and opiate agonists at the spinal level in rodents. Anesth 
Analg 68, 194–200. 
Paalzow G & Paalzow L (1983). Yohimbine both increases and decreases 
nociceptive thresholds in rats: evaluation of the dose-response relationship. 
Naunyn Schmiedebergs Arch Pharmacol 322, 193–197. 
Palazzo E, Guida F, Gatta L, Luongo L, Boccella S, Bellini G, Marabese I, de 
Novellis V, Rossi F & Maione S (2011). EP1 receptor within the ventrolateral 
periaqueductal grey controls thermonociception and rostral ventromedial 
medulla cell activity in healthy and neuropathic rat. Mol Pain 7, 82. 
Pertovaara A (2006). Noradrenergic pain modulation. Prog Neurobiol 80, 53–83. 
Pertovaara A (2013). The noradrenergic pain regulation system: A potential target for 
pain therapy. Eur J Pharmacol 716, 2–7. 
Provitera V, Nolano M, Pagano A, Caporaso G, Stancanelli A & Santoro L (2007). 
Myelinated nerve endings in human skin. Muscle Nerve 35, 767–775. 
Przewłocki R & Przewłocka B (2001). Opioids in chronic pain. Eur J Pharmacol 429, 
79–91. 
Reed RK & Rubin K (2010). Transcapillary exchange: role and importance of the 
interstitial fluid pressure and the extracellular matrix. Cardiovasc Res 87, 211–
217. 
Ren K & Dubner R (1996). Enhanced descending modulation of nociception in rats 
with persistent hindpaw inflammation. J Neurophysiol 76, 3025–3037. 
Ren K & Dubner R (1999). Inflammatory models of pain and hyperalgesia. ILAR J 40, 
111–118. 
Sandrini G, Serrao M, Rossi P, Romaniello A, Cruccu G & Willer JC (2005). The 
lower limb flexion reflex in humans. Prog Neurobiol 77, 353–395. 
Schouenborg J, Weng H & Holmberg H (1994). Modular organization of spinal 
nociceptive reflexes : A new hypothesis. Physiology 9, 261–265. 
Sivilotti LG, Thompson SWN & Woolf CJ (1993). Rate of rise of the cumulative 
depolarization evoked by repetitive stimulation of small-caliber afferents is a 
predictor of action potential windup in rat spinal neurons in vitro. J Neurophysiol 
69, 1621–1631. 
Soignier RD, Taylor BK, Baiamonte BA, Lee FA, Paul D & Gould HJ (2011). 
Measurement of CFA-induced hyperalgesia and morphine-induced analgesia in 
rats: dorsal vs plantar mechanical stimulation of the hindpaw. Pain Med 12, 
451–458. 
Stanfa L & Dickenson A (1995). Spinal opioid systems in inflammation. Inflamm Res 
44, 231–241. 
Differential descending control of inputs from hairy vs. glabrous skin 
 
 
35
Størkson R V, Kjørsvik A, Tjølsen A & Hole K (1996). Lumbar catheterization of the 
spinal subarachnoid space in the rat. J Neurosci Methods 65, 167–172. 
Suzuki R, Morcuende S, Webber M, Hunt SP & Dickenson AH (2002). Superficial 
NK1-expressing neurons control spinal excitability through activation of 
descending pathways. Nat Neurosci 5, 1319–1326. 
Takano Y & Yaksh TL (1992). Characterization of the pharmacology of intrathecally 
administered alpha-2 agonists and antagonists in rats. J Pharmacol Exp Ther 
261, 764–772. 
Terayama R, Dubner R & Ren K (2002). The roles of NMDA receptor activation and 
nucleus reticularis gigantocellularis in the time-dependent changes in 
descending inhibition after inflammation. Pain 97, 171–181. 
Tsuruoka M, Matsutani K & Inoue T (2003). Coeruleospinal inhibition of nociceptive 
processing in the dorsal horn during unilateral hindpaw inflammation in the rat. 
Pain 104, 353–361. 
Tsuruoka M, Tamaki J, Maeda M, Hayashi B & Inoue T (2012). Biological 
implications of coeruleospinal inhibition of nociceptive processing in the spinal 
cord. Front Integr Neurosci 6, 87. 
Tsuruoka M & Willis WD (1996). Descending modulation from the region of the locus 
coeruleus on nociceptive sensitivity in a rat model of inflammatory hyperalgesia. 
Brain Res 743, 86–92. 
Tyce GM & Yaksht TL (1981). Monoamine release from cat spinal cord by somatic 
stimuli: an intrinsic modulatory system. J Physiol 314, 513–529. 
Vanegas H & Schaible HG (2004). Descending control of persistent pain: inhibitory or 
facilitatory? Brain Res Rev 46, 295–309. 
Wang W, Wu S-X, Wang Y-Y, Liu X-Y & Li Y-Q (2003). 5-Hydroxytryptamine1A 
receptor is involved in the bee venom induced inflammatory pain. Pain 106, 
135–142. 
Westlund KN, Bowker RM, Ziegler MG CJ (1983). Noradrenergic projections to the 
spinal cord of the rat. Brain Res 263, 15–31. 
Wiesenfeld-Hallin Z (1995). Neuropeptides and spinal cord reflexes. Prog Brain Res 
104, 271–280. 
Woolf CJ & Wall PD (1986). Relative effectiveness of C primary afferent fibers of 
different origins in evoking a prolonged facilitation of the flexor reflex in the rat. J 
Neurosci 6, 1433–1442. 
Yeomans DC & Proudfit HK (1996b). Nociceptive responses to high and low rates of 
noxious cutaneous heating are mediated by different nociceptors in the rat: 
Electrophysiological evidence. Pain 68, 141–150. 
Differential descending control of inputs from hairy vs. glabrous skin 
 
 
36
Yeomans DC & Proudfit HK (1996a). Nociceptive responses to high and low rates of 
noxious cutaneous heating are mediated by different nociceptors in the rat: 
electrophysiological evidence. Pain 68, 141–150. 
Yoshimura M & Furue H (2006). Mechanisms for the anti-nociceptive actions of the 
descending noradrenergic and serotonergic systems in the spinal cord. J 
Pharmacol Sci 101, 107–117. 
You H-J, Lei J, Sui M-Y, Huang L, Tan Y-X, Tjølsen A & Arendt-Nielsen L (2010). 
Endogenous descending modulation: spatiotemporal effect of dynamic 
imbalance between descending facilitation and inhibition of nociception. J 
Physiol 588, 4177–4188. 
Yu Z, Aihui L, Jiajia X, Lixing L, Ke R, Brian B, Ming T & Zhang R-X (2011). 
Involvement of spinal serotonin receptors in electroacupuncture anti-
hyperalgesia in an inflammatory pain rat model. Neurochem Res 36, 1785–
1792. 
Zhang Y, Yang Z, Gao X & Wu G (2001). The role of 5-hydroxytryptamine1A and 5-
hydroxytryptamine1B receptors in modulating spinal nociceptive transmission in 
normal and carrageenan-injected rats. Pain 92, 201–211. 
Ziegler EA, Magerl W, Meyer RA & Treede RD (1999). Secondary hyperalgesia to 
punctate mechanical stimuli. Central sensitization to A-fibre nociceptor input. 
Brain 122 (Pt 1), 2245–2257. 
Differential descending control of inputs from hairy vs. glabrous skin 
 
 
37
Figure legends 
Figure 1: A single subcutaneous injection of CFA into the hind-paw dorsum 
leads to a primary mechanical but not thermal hyperalgesia.  
A. Delivery of CFA (50µl) into the hind-paw dorsum produced significant oedema 
(one-way RM ANOVA; p<0.0001, F(4,3)=33.54, Bonferroni’s post-test *p<0.001 
compared to baseline, n=4).  
B. CFA-induced inflammation was associated with a primary mechanical 
hyperalgesia (one-way RM ANOVA; p<0.001, F(3,3)=7.13, Bonferroni’s post-test 
*p<0.05 compared to baseline, n=4). 
C. CFA-induced inflammation did not however result in thermal hyperalgesia (n=4). 
D. In contrast, a 50µl s.c. injection of CFA into the plantar surface of the hind-paw 
produced a persistent primary thermal hyperalgesia (one-way RM ANOVA; p<0.05, 
F(3,2)=11.88, Bonferroni’s post-test, *p<0.05 compared to baseline, n=3).  
 
 
Figure 2: A single subcutaneous injection of CFA into the hind-paw dorsum 
produces a transient sensitisation of withdrawal reflexes to A- and C-
nociceptor activation.  
A. CFA-induced inflammation of the dorsal hind-paw resulted in a transient reduction 
in the withdrawal threshold to A-nociceptor stimulation that resolved fully by 3 hours 
after CFA injection (one-way RM ANOVA, p<0.0001, F(3,4)=21.22, Bonferroni’s post-
test ***p<0.001 compared to baseline, n=5). 
B. Responses to C-nociceptor activation showed that inflammation resulted in an 
even more transient response, resolving after 2 hours (one-way RM ANOVA, 
P<0.0001, F(3,4)=20.39, Bonferroni’s post-test *p<0.001 compared to baseline, n=5). 
An equivalent injection of vehicle (mineral oil) had no significant effect on withdrawal 
thresholds to A- or C-nociceptor activation (Mineral oil group, A&B, Friedman test, 
p>0.05, n=3)  
Differential descending control of inputs from hairy vs. glabrous skin 
 
 
38
C. A larger dose of CFA (100µg/100µl) resulted in a more rapid resolution of 
sensitisation to A-nociceptor activation, causing a more rapid return to baseline (two-
way RM ANOVA; main dose effect: p=0.08, F(3,1)=3.98, Bonferroni’s post-test 
*p<0.05 between groups, n=5 for both groups). 
D. A larger dose of CFA (100µg) resulted in a more rapid resolution of sensitisation 
to C-nociceptor activation so that withdrawal thresholds were significantly higher 
compared to a 50µg dose at the one hour time point  (two-way RM ANOVA; Main 
dose effect: p=0.0022, F(3,1)=19.53, Bonferroni’s post-test *** p<0.001 between 
groups, n=5 for both groups).   
 
Figure 3: Sensitisation resulting from acute inflammation of the plantar 
hindpaw is unaffected by intrathecal yohimbine.  
Acute CFA-induced inflammation of the plantar hind-paw resulted in a reduction in 
thermal withdrawal threshold that persisted for the 3 hours tested (one-way RM 
ANOVA; p<0.0001, F(3,4)=19.30, Bonferroni’s post-test ***p<0.001, **p<0.01 
compared to baseline). This was unaffected by intrathecal yohimbine at 3h following 
CFA (n=5 CFA, n=4 CFA+yoh).  
  
Figure 4: Paw swelling is different following CFA injection into dorsal or 
plantar hindpaw. 
Injection of 50µg CFA resulted in greater swelling in the plantar compared to the 
dorsal surface of the hindpaw. Injection of a larger CFA concentration (100µg) in the 
dorsal surface did not increase the swelling above that caused by 50µg. (one way 
ANOVA, p<0.0001 F(12, 70)=59.13, Bonferroni post-hoc tests *p<0.05 plantar c.f. 
both other groups, data shown as mean±SD). 
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Figure 5: Blockade of spinal alpha 2 adrenoceptors reveals a rapid inhibitory 
control on withdrawal reflexes to A- and C-nociceptor activation during acute 
inflammation.  
A. The loss of acute sensitisation to A-nociceptor stimulation 3 hours after CFA 
injection was partially reversed by the intrathecal injection of the noradrenergic alpha 
2 receptor antagonist yohimbine (Mann-Whitney U, *p<0.05, n=7 CFA (3h), n=5 yoh). 
B. The loss of acute sensitisation to C-nociceptor stimulation 3 hours after CFA 
injection was reversed by yohimbine (Mann-Whitney U, *p<0.05, n=8 CFA (3h), n=5 
yoh). 
C. Systemic administration of the pan-opioid antagonist, naloxone, had no effect on 
either A-nociceptor evoked withdrawals (CFA n=5, CFA+nal n=6) or on D. C-
nociceptor evoked withdrawals (CFA n=5, CFA+nal n=6).  
 
 
 





